New Release
Molecular Biology of SARS-CoV-2
Opportunities for Antivirus Drug Development
Edition:
1
ISBN/ISSN:
9781975231347
Publication Date:
June 19, 2024
2024-06-19
9781975231347
Your enhanced VST eBook includes a full suite of study tools on any device—both online and offline: Anytime, anywhere access ...
Read More
-
-
Your enhanced VST eBook includes a full suite of study tools on any device—both online and offline:
- Anytime, anywhere access – study on the go with 100% offline access to your downloaded title
- Margin notes – make annotations as you are reading
- Read aloud – listen and follow along as your book is read to you
- Workbook – improve your focus as you edit notes, add bookmarks, and review key concepts in one place
- Global search – search across book content, figures, and your workbook
- Reviews the basic science, clinical data and various perspectives on how SARS-CoV-2 infects cells, replicates, manipulates cellular machinery, evades host defenses, and is transmitted to other hosts
- Covers the origin and structure of SARS-CoV-2, followed by chapters based on the life cycle of the virus
- Provides a thorough review of what is known for each molecular component of the viral life cycle while incorporating information on pertinent prevention and therapeutic interventions
About the Authors
Roberto Patarca, MD, PhD
Dr. Patarca is the Chief Medical Officer at ACCESS Health International and a former pharmaceutical and medical device company executive and faculty at Harvard Medical School and the University of Miami. His research has focused on the AIDS virus, microbial replication regulation, adoptive cellular immunotherapy, drug resistance testing, cardiovascular interventions, and chronic fatigue syndrome.
He served on Advisory Committees to two U.S. Secretaries of Health and Human Services, was elected to the Academy of Sciences of Latin America; worked with the World Health Organization on standardization of cytokine level measurements, and has been published widely.
William A. Haseltine, PhD
In Dr. Haseltine’s career at the forefront of medical research and application, he has educated a generation of doctors at Harvard Medical School, designed the strategy to develop the first treatment for HIV/AIDS, is well-known for his groundbreaking work on cancer, and led the team that pioneered the development of new drugs based on information from the human genome.
He is the author of more than two hundred peer-reviewed manuscripts and fifteen books. As Chair and CEO of ACCESS Health International, Dr. Haseltine is dedicated to ensuring that advances in medical technology translate to improved health outcomes worldwide. -
Edition1ISBN/ISSN9781975231347Product FormatVitalsource Interactive eBookEdition1Publication DateJune 19, 2024
-
- William A. Haseltine
USD $199.99
159.99
USD $159.99
IN STOCK
Quantity:
1
Buy from another retailer
Added To Your Cart
Molecular Biology of SARS-CoV-2
ISBN/ISSN: 9781975231347
USD $199.99
Quantity :
Recommended For You
YOU MIGHT ALSO LIKE
